Divi's Laboratories lifts Q2 net profit to ₹1,127 crore
Divi's Laboratories raised quarterly profit to ₹1,127 crore and H1 profit reached ₹2,029 crore, while operating cash inflow fell sharply.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Divi's Laboratories reported that for the second quarter of fiscal 2027, consolidated total income reached ₹3,770 crore and net profit came in at ₹1,127 crore. Both figures were higher than a year earlier.
For the first half, the company's profit totaled ₹2,029 crore. Operating cash inflow, however, was ₹384 crore, compared with ₹1,645 crore in the first half of the previous fiscal year. The information was published by TradingView.
why it matters
Profit growth alongside a sharp drop in operating cash flow may draw investors' attention, as they will judge how well reported earnings are backed by actual cash receipts. For India's pharmaceutical sector, this is an important measure of reporting quality.
market impact
Indian pharma: profit growth with weaker cash flow puts focus on reporting quality
tags
instruments
sources
- DIVISLAB: Q2 PAT rose to ₹1,127 crore; H1 PAT reached ₹2,029 crore — TradingView, 7 November 2026 at 06:29 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗